SME Times is powered by   
Search News
Just in:   • Adani Group to invest Rs 57,575 crore in Odisha  • 'Dollar Distancing' finally happening? Time for India to pitch Rupee as credible alternative: SBI Ecowrap  • 49% Indian startups now from tier 2, 3 cities: Jitendra Singh  • 'India ranks 3rd in global startup ecosystem & number of unicorns'  • LinkedIn lays off entire global events marketing team: Report 
Last updated: 02 May, 2015  

snapdeal.thumb.jpg FDA orders FIR against Snapdeal.com top brass

snapdeal.jpg
   Top Stories
» 49% Indian startups now from tier 2, 3 cities: Jitendra Singh
» 'India ranks 3rd in global startup ecosystem & number of unicorns'
» Tripura exported over 9K tonnes of pineapples in 2 years
» CPI inflation eases to 6.71% in July, IIP falls to 12.3%
» Rupee depreciates 12 paise to close at 79.64 against US dollar
SME Times News Bureau | 02 May, 2015
 The Maharashtra Food and Drugs Administration (FDA) has ordered the filing of a first information report (FIR) against e-commerce major Snapdeal.com's CEO, directors and distributors on charges of selling prescription drugs online, a top official said Mumbai on Friday.

FDA Commissioner Harshadeep Kamble said that the action follows raids and investigations against Snapdeal.com over the past two weeks.

"Despite a written assurance from the company, it was found that Snapdeal.com continued to offer, exhibit and sell drugs like I-Pill, Unwanted-72 and emergency contraceptive drugs through their website. We ordered these drugs online and received them on April 24," Kamble told IANS.

When contacted, a spokesperson for Snapdeal.com in New Delhi assured that a concerned person would comment on the FDA actions soon.

Kamble said the company's actions contravened the Drugs and Cosmetics Act, 1940.

He explained that only a certified medical practitioner can sell the Schedule H drugs and only when prescribed by a doctor.

Since such type of online sale of drugs is not allowed, the FDA has ordered lodging of police complaints against Snapdeal.com CEO Kunal Bahl, other directors of the company and distributors of the drug.
 
Print the Page Add to Favorite
 
Share this on :
 

Please comment on this story:
 
Subject :
Message:
(Maximum 1500 characters)  Characters left 1500
Your name:
 

 
  Customs Exchange Rates
Currency Import Export
US Dollar
66.20
64.50
UK Pound
87.50
84.65
Euro
78.25
75.65
Japanese Yen 58.85 56.85
As on 13 Aug, 2022
  Daily Poll
PM Modi's recent US visit to redefine India-US bilateral relations
 Yes
 No
 Can't say
  Commented Stories
» GIC Re's revenue from obligatory cession threatened(1)
 
 
About Us  |   Advertise with Us  
  Useful Links  |   Terms and Conditions  |   Disclaimer  |   Contact Us  
Follow Us : Facebook Twitter